acetazolamide extended-release

Generic: acetazolamide extended-release

Labeler: micro labs limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetazolamide extended-release
Generic Name acetazolamide extended-release
Labeler micro labs limited
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

acetazolamide 500 mg/1

Manufacturer
Micro Labs Limited

Identifiers & Regulatory

Product NDC 42571-243
Product ID 42571-243_456f5ce4-6ad1-f0a1-e063-6294a90a0fac
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207401
Listing Expiration 2026-12-31
Marketing Start 2020-12-01

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42571243
Hyphenated Format 42571-243

Supplemental Identifiers

RxCUI
562524
UPC
0342571243012
UNII
O3FX965V0I
NUI
N0000175517 N0000000235 M0020790

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetazolamide extended-release (source: ndc)
Generic Name acetazolamide extended-release (source: ndc)
Application Number ANDA207401 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 500 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (42571-243-01)
source: ndc

Packages (1)

42571-243-01 100 CAPSULE in 1 BOTTLE (42571-243-01)

Ingredients (1)

acetazolamide (500 mg/1)

Linked Drug Pages (1)

ACETAZOLAMIDE EXTENDED-RELEASE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "456f5ce4-6ad1-f0a1-e063-6294a90a0fac", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0342571243012"], "unii": ["O3FX965V0I"], "rxcui": ["562524"], "spl_set_id": ["78f78919-a6ba-4072-bc45-2ab3637ed894"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (42571-243-01)", "package_ndc": "42571-243-01", "marketing_start_date": "20201201"}], "brand_name": "ACETAZOLAMIDE EXTENDED-RELEASE", "product_id": "42571-243_456f5ce4-6ad1-f0a1-e063-6294a90a0fac", "dosage_form": "CAPSULE", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "42571-243", "generic_name": "Acetazolamide extended-release", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACETAZOLAMIDE EXTENDED-RELEASE", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "500 mg/1"}], "application_number": "ANDA207401", "marketing_category": "ANDA", "marketing_start_date": "20201201", "listing_expiration_date": "20261231"}